Mumbai: Senores Pharmaceuticals reported a significant year-on-year surge in its Profit After Tax (PAT) for Q3FY26 increasing 105% to ₹34…
Trending
- Where do you draw the line? The myth behind our Digital Privacy habits
- Sonia Gandhi and Manmohan Singh: A partnership that shaped India’s economy
- Nvidia’s biggest leadership test begins: Can Colette Kress replace Jensen Huang?
- Entrepreneurship Is Continuous Learning
- Parul Sharma on Building Gladful and the Future of Healthy Foods
- Why Adani is looking to Chile for Copper as India’s industrial demand surges
- ABBS Launches Cohort 2 of Free Startup Incubation Programme to Nurture Emerging Entrepreneurs
- Who will lead Nvidia if Jensen Huang exits? Inside the chipmaker’s succession challenge
